
Keywords: ACL; Aceclofenac; AUC; area under the curve; BBB; blood-brain barrier; BCS; Biopharmaceutical classification system; BVC; bupivacaine; CNS; central nervous system; CUR; Curcumin; DMBA; 7,12-dimethylbenzanthracene; DOX; doxorubicin; DSPE-PEG2000; 1,2-diste